Pharmaceutical products
Titre original de l'avis
Germany-Hamburg: Pharmaceutical products
Score d'opportunité
Pourquoi ce score ?
Opportunité
65 / 100
Complexité
40 / 100
Facteurs de risque
The procedure is a voluntary transparency notice, not a public contract under EU directives. Bidders have no procuremen...
No estimated value or guaranteed volume means uncertain revenue. Discounts may be substantial and profitability depends...
No procurement documents available
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Strong opportunityFaits clés
- Supplies contract
- 3 lots
- Supply of pharmaceutical products under non-exclusive discount agreements for specified active substances.
- Agreements aim to bridge the period between patent expiry and exclusive discount contracts.
Afficher le résumé complet
Open house procedure for non-exclusive discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for pharmaceutical products. The notice is a voluntary transparency notice, not a public procurement subject to EU directives. The procedure is open to all qualified pharmaceutical entrepreneurs, with contracts awarded to all who meet the requirements. The contract runs from 1 November 2023 to 31 October 2026, with a possible 6-month extension. Ten lots cover various active substances. No estimated value is provided. Submission of participation and contract documents is electronic via the portal, with continuous accession possible during the contract term.
Risques
The procedure is a voluntary transparency notice, not a public contract under EU directives. Bidders have no procuremen...
No estimated value or guaranteed volume means uncertain revenue. Discounts may be substantial and profitability depends...
No procurement documents available
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Administrative
- Participation is open to pharmaceutical entrepreneurs (as defined in §4 Abs. 18 AMG) who submit a declaration of suitability and reliability.
- Bid submission via electronic portal; documents must be submitted with qualified electronic signature or signed original.
- For timely inclusion of discount pricing in pharmacy software, complete documents must be received by the 3rd of the month prior to the desired start month.
Les exigences peuvent être incomplètes.
Acheteur
Localisation
Karlsruhe, DEU
Site web
Activité
Defence
Lots (3)
01
Carbamazepine (RET, N1, N2, N3) - TK, HEK, hkk
Discount agreement for Carbamazepine in specified forms, for participating health insurance funds TK, HEK, and hkk.
Catégorie
Date limite
02
Ciclosporin (WKA) - TK, HEK, hkk
Discount agreement for Ciclosporin in specified form, for TK, HEK, hkk.
Catégorie
Date limite
03
Levothyroxine sodium (excluding WKA, LSE, TRO, ILO) - TK
Discount agreement for Levothyroxine sodium in specified forms, for TK only.
Catégorie
Date limite
Détails de la procédure
- Date de publication
- 19 Sep 2023
- Langues
- German
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 566780-2023
Appels d'offres similaires
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Belgium – Pharmaceutical products – Antimycotica
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
France – Pharmaceutical products – 26-10 : ACCORD-CADRE DE FOURNITURE DE MÉDICAMENTS 2026
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Score d'opportunité
Pourquoi ce score ?
Opportunité
65 / 100
Complexité
40 / 100
Facteurs de risque
The procedure is a voluntary transparency notice, not a public contract under EU directives. Bidders have no procuremen...
No estimated value or guaranteed volume means uncertain revenue. Discounts may be substantial and profitability depends...
No procurement documents available
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications